Citation: B. Gardner et al., The role of phosphorylation/dephosphorylation in agonist-induced desensitization of D-1 dopamine receptor function: Evidence for a novel pathway for receptor dephosphorylation, MOLEC PHARM, 59(2), 2001, pp. 310-321
Citation: Ja. Schetz et Dr. Sibley, The binding-site crevice of the D-4 dopamine receptor is coupled to three distinct sites of allosteric modulation, J PHARM EXP, 296(2), 2001, pp. 359-363
Citation: Ja. Schetz et al., Nonconserved residues in the second transmembrane-spanning domain of the D-4 dopamine receptor are molecular determinants of D-4-selective pharmacology, MOLEC PHARM, 57(1), 2000, pp. 144-152
Citation: Alm. Ventura et Dr. Sibley, Altered regulation of the D-1 dopamine receptor in mutant Chinese hamster ovary cells deficient in cyclic AMP-dependent protein kinase activity, J PHARM EXP, 293(2), 2000, pp. 426-434
Citation: Ja. Schetz et Dr. Sibley, Tandem sulfur-containing amino acids are epicritical determinants of dopamine D-2 receptor pharmacology, EUR J PHARM, 388(2), 2000, pp. R5-R7
Citation: A. Cravchik et al., Analysis of neuroleptic binding affinities and potencies for the differenthuman D-2 dopamine receptor missense variants, PHARMACOGEN, 9(1), 1999, pp. 17-23
Authors:
Lawler, CP
Prioleau, C
Lewis, MM
Mak, C
Jiang, D
Schetz, JA
Gonzalez, AM
Sibley, DR
Mailman, RB
Citation: Cp. Lawler et al., Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes, NEUROPSYCH, 20(6), 1999, pp. 612-627
Authors:
Liu, LX
Burgess, LH
Gonzalez, AM
Sibley, DR
Chiodo, LA
Citation: Lx. Liu et al., D-2S, D-2L, D-3, and D-4 dopamine receptors couple to a voltage-dependent potassium current in N18TG2 x mesencephalon hybrid cell (MES-23.5) via distinct G proteins, SYNAPSE, 31(2), 1999, pp. 108-118
Authors:
Cepeda, C
Li, Z
Cromwell, HC
Altemus, KL
Crawford, CA
Nansen, EA
Ariano, MA
Sibley, DR
Peacock, WJ
Mathern, GW
Levine, MS
Citation: C. Cepeda et al., Electrophysiological and morphological analyses of cortical neurons obtained from children with catastrophic epilepsy: Dopamine receptor modulation of glutamatergic responses, DEV NEUROSC, 21(3-5), 1999, pp. 223-235
Citation: Dr. Sibley, New insights into dopaminergic receptor function using antisense and genetically altered animals, ANN R PHARM, 39, 1999, pp. 313-341
Authors:
Clifford, JJ
Tighe, O
Croke, DT
Kinsella, A
Sibley, DR
Drago, J
Waddington, JL
Citation: Jj. Clifford et al., Conservation of behavioural topography to dopamine D-1-like receptor agonists in mutant mice lacking the D-1A receptor implicates a D-1-like receptornot coupled to adenylyl cyclase, NEUROSCIENC, 93(4), 1999, pp. 1483-1489
Citation: D. Jiang et Dr. Sibley, Regulation of D-1 dopamine receptors with mutations of protein kinase phosphorylation sites: Attenuation of the rate of agonist-induced desensitization, MOLEC PHARM, 56(4), 1999, pp. 675-683
Authors:
Clifford, JJ
Tighe, O
Croke, DT
Sibley, DR
Drago, J
Waddington, JL
Citation: Jj. Clifford et al., Topographical evaluation of the phenotype of spontaneous behaviour in micewith targeted gene deletion of the D-1A dopamine receptor: paradoxical elevation of grooming syntax, NEUROPHARM, 37(12), 1998, pp. 1595-1602